Company Filing History:
Years Active: 2003
Title: The Innovations of David Higgins
Introduction
David Higgins is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biomedical research, particularly in the area of inflammation and organ transplantation. His work has the potential to enhance the viability of organ transplants and improve patient outcomes.
Latest Patents
Higgins holds a patent titled "Inhibition of inflammation using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors." This invention provides methods for expanding and increasing the survival of hematopoietic cell populations. It also focuses on prolonging the viability of organs for transplantation and enhancing bioproduction through the use of ICE/CED-3 family inhibitors. His innovative approach includes exemplary compounds that are useful in these methods.
Career Highlights
David Higgins is currently associated with Idun Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is crucial in the ongoing quest to improve medical treatments and patient care.
Collaborations
Higgins collaborates with esteemed colleagues such as Lawrence C. Fritz and Kevin J. Tomaselli. Their combined expertise contributes to the success of their projects and the advancement of their research goals.
Conclusion
David Higgins is a prominent figure in the field of biomedical innovation, with a focus on improving organ transplantation and patient care through his patented inventions. His contributions are paving the way for future advancements in medical science.